Vallentuna, Sweden

Rolf G Sterlund

This inventor holds 2 USPTO granted patents. Top assignee: Kabivitrum Ab. Active years: 1985-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rolf G Sterlund. Retrieved from https://idiyas.com/inventor/rolf-g-sterlund

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1985-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rolf G Sterlund: Innovating Pharmaceutical Solutions

Introduction

Rolf G Sterlund, a notable inventor based in Vallentuna, Sweden, has made significant contributions to the field of pharmaceuticals. With two patents to his name, he focuses on innovative solutions that enhance medical treatments.

Latest Patents

Rolf's latest patents revolve around a novel pharmaceutical composition. This innovative complex pairs carrageenan with a member of a specialized group consisting of emepronium, doxycycline, and propranolol. The pharmaceutical preparations derived from this complex are aimed at improving various medical applications.

Career Highlights

Rolf is associated with Kabivitrum AB, a company that focuses on pharmaceutical advancements. His work has garnered attention due to the potential benefits of his patented compositions in the medical field.

Collaborations

Throughout his career, Rolf has collaborated with various professionals, including his coworker, Carl-Aage Bergwitz-Larsen. Such collaborations have enabled him to further enhance his innovative approaches to pharmaceutical development.

Conclusion

In conclusion, Rolf G Sterlund's inventive spirit and dedication to improving pharmaceutical compositions underscore the importance of innovation in medicine. His contributions continue to pave the way for advancements that may significantly impact treatment methodologies in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…